AC Immune (ACIU) Q4 2024 Earnings
ACIU·Reported March 13, 2025·Before market open
AC Immune reported Q4 2024 revenue of $1.3M, beat analyst consensus of $819.5K by $432.5K. Diluted EPS came in at $-0.18, beat the $-0.21 consensus by $0.03.
Revenue
$1.3Mbeat by $432.5K
Consensus: $819.5KDiluted EPS
$-0.18beat by $0.03
Consensus: $-0.21
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about AC Immune's Q4 2024 earnings report.
AC Immune (ACIU) reported Q4 2024 earnings on March 13, 2025 before market open.
AC Immune reported revenue of $1.3M and diluted EPS of $-0.18 for Q4 2024.
Revenue beat the consensus estimate of $819.5K by $432.5K. EPS beat the consensus estimate of $-0.21 by $0.03.